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What’s New?: Urothelial cell carcinoma (UCC) is the most common form of bladder 
cancer. Previous studies suggested that plasma carotenoids, antioxidants found in 
fruit and vegetables, were associated with a decreased risk of UCC while a high 
intake of animal protein was associated with an increased cancer risk. Here, the 
authors conducted the first study to investigate the association between the 
Mediterranean diet, a diet rich in fresh fruits and vegetables and low in animal 
products, and UCC in Europe. They found that adherence to a Mediterranean diet 
was not significantly associated with UCC, regardless of level of tumour 
aggressiveness. They point out that these findings are in line with the rather weak 
evidence for questionnaire-based associations between dietary factors and bladder 
cancer risk. 
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Abstract 
There is evidence on the protective role of the Mediterranean diet on cancer. 
However, to date no epidemiological study to date has investigated the influence of 
the Mediterranean diet on bladder cancer. Therefore, we evaluated the association 
between adherence to the Mediterranean diet and risk of urothelial cell bladder 
cancer (UCC), according to prognostic risk group (tumor aggressiveness), in the 
European Prospective Investigation into Cancer and Nutrition (EPIC). 
The analysis included 477,312 participants, recruited from ten European countries 
between 1991 and 2000. Information from validated dietary questionnaires was used 
to develop a relative Mediterranean diet score (rMED), including nine dietary 
components. Cox regression models were used to assess the effect of the rMED on 
UCC risk, while adjusting for dietary energy and tobacco smoking of any kind. 
Stratified analyses were performed by sex, BMI, smoking status, European region 
and age at diagnosis. During an average follow-up of 11 years, 1,425 participants 
(70.9% male) were diagnosed with a first primary UCC. There was a negative but 
non-significant association between a high versus low rMED score and risk of UCC 
overall (HR: 0.84 [95% CI 0.69, 1.03]) and risk of aggressive (HR: 0.88 [95% CI 0.61, 
1.28]) and non-aggressive tumors (HR: 0.78 [95% CI 0.54, 1.14]). Although there 
was no effect modification in the stratified analyses, there was a significant 34% (p 
50.043) decreased risk of UCC in current smokers with a high rMED score. In EPIC, 
the MD was not significantly associated with risk of UCC, although we cannot 
exclude that a MD may reduce risk in current smokers. 
  5 
Introduction 
There is evidence that the Mediterranean dietary pattern has a protective role on risk 
of overall and specific types of cancer incidence and mortality.(1-4) To our 
knowledge though, no epidemiological study to date has investigated the influence of 
the Mediterranean diet (MD) on bladder cancer. Bladder cancer is the eighth most 
common type of cancer in the world (5) and established risk factors include tobacco 
smoking, occupational exposure to aromatic amine carcinogens and Schistosoma 
haematobium infection (6-7). 
 
Various dietary factors have also been suggested to be related to bladder cancer.8,9 
However, the 2007 WCRF/AICR report6 concluded that the strength of evidence was 
“limited” to conclude that specific food groups, such as fruit and vegetables, fat, meat 
or red meat and dairy products, modify bladder cancer risk. Since the WCRF/AICR 
report, the European Prospective Investigation into Nutrition and Cancer (EPIC) 
study, the same cohort analyzed in this article, has published results showing that 
plasma carotenoids (important antioxidants found primarily in fruit and vegetables) 
were associated with a decreased risk of urothelial cell carcinoma (UCC), the 
predominant cell type of bladder cancer. In addition, both a high intake of energy 
from animal protein and a low intake of energy from plant protein were related to 
increased risk of UCC in this cohort (10).  
 
Therefore, there is tentative evidence that certain features characteristic of the MD 
pattern (a plant-based diet rich in antioxidants such as carotenoids and relatively low 
in animal-derived products and animal protein), may have a beneficial effect on the 
risk of bladder cancer. Consequently, we aimed to investigate the association 
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between adherence to the Mediterranean dietary pattern and risk of UCC within the 
EPIC cohort. 
 
MATERIAL AND METHODS 
 
Study population and data collection 
EPIC is an ongoing prospective cohort study involving 23 centres in 10 European 
countries (Denmark, France, Greece, Italy, the Netherlands, Norway, Spain, Sweden 
and the United Kingdom). The full rational, methods and design details have been 
described previously (11,12). In brief, 521,454 participants aged mostly 25-70 years 
old were recruited from 1992-2000, mainly from the general population or defined 
geographical area, town or province, but with some exceptions (12). At baseline 
validated country-specific questionnaires were used to record the usual diet during 
the previous year and to capture local dietary patterns (12,13). Lifestyle 
questionnaires were used to obtain information on socio-demographic 
characteristics, physical activity, medical history, and alcohol and tobacco 
consumption. Anthropometric measures were also ascertained at recruitment.  
All participants gave written informed consent and the relevant ethics committees 
approved the study. Participants were excluded if they had been registered as having 
cancer previously or if they had missing end of follow-up data (n 5 28,289), missing 
information on diet or lifestyle (n 5 6,253) or a ratio for energy intake versus energy 
expenditure in the top and bottom 1% (n 5 9,600), leaving 477,312 participants for 
the current analysis. 
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Outcome Assessment 
Incident bladder cancer cases were identified by population cancer registries for 
Denmark, Italy, The Netherlands, Norway, Spain, Sweden and the United Kingdom. 
A combination of methods were used in France, Germany and Greece, as detailed 
previously.(12). Mortality data were also obtained from regional or national mortality 
registries. Censoring dates for the last complete follow-up ranged from December 
2004 to June 2010, depending on the center. The follow-up period was defined from 
age at recruitment until age at diagnosis of a first cancer (of any type), death or last 
complete follow-up, depending on which occurred first. Participants diagnosed with a 
cancer other than bladder cancer during follow-up were censored at the date of 
diagnosis of their first tumor. Cases were defined as subjects with a first primary 
bladder cancer, coded as C67 using International Classification of Diseases for 
Oncology Third Edition (ICD-O-3), which occurred during follow-up. The analysis only 
included the urothelial cell papillomas and transitional cell carcinomas 
(morphology/behavior codes 8120/1, 8120/2, 8120/3, 8122/3, 8130/1, 8130/2 and 
8130/3), as these make up more than 90% of bladder tumors, and they are referred 
to now on as urothelial cell carcinomas (UCC).10 Other bladder cancer morphologies 
were censored at date of diagnosis (10,14). The UCC cases were separated into 
relatively aggressive (high risk of progression) and non-aggressive (low risk of 
progression), (15) as described previously.(16) Tumor aggressiveness was only 
classified for bladder cancer cases diagnosed up until 2007, as these have been 
individually validated by pathology reports, and the remaining tumors were censored 
at date of diagnosis for stratified analyses. 
 
 
The relative Mediterranean diet (rMED) score 
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Level of adherence to a traditional MD was estimated using the relative 
Mediterranean diet score (rMED),(17) an adapted version of the original MD score by 
Trichopoulou et al. (18). The rMED is an 18-point linear score that incorporates nine 
key dietary components; seven components presumed to reflect the MD (fruit, nuts 
and seeds [one component combined], vegetables, legumes, fish, olive oil and 
cereals) and two components presumed not to reflect the MD (dairy products and 
meat), calculated as a function of energy density (g/day/2,000 kcal) and divided into 
tertiles. The scoring system has been detailed previously.(17) The rMED also 
includes alcohol, scored by assigning two to moderate consumers (ranging from 5 to 
25 g/day for women and 10–50 g/ day for men) and 0 to participants outside this sex-
specific range. The rMED score ranged from 0 to 18 (lowest to highest adherence). 
 
Statistical Analysis 
Analyses were preformed using Stata version 10 (Statacorp, College Station, TX). 
Cox proportional hazards regression models were used to assess the association 
between the rMED score and UCC risk. Age was the primary time variable used. All 
models were stratified by sex, age at EPIC study entry (1 year intervals) and EPIC 
center. All models were adjusted for total energy intake (kcal/day, continuous), 
smoking status (11 categories: never smoker (never smoked tobacco of any kind but 
exposed or unknown exposure to second-hand smoke at work/home), true never 
smokers (never smoked tobacco of any kind and never exposed to second-hand 
smoke at work/home), current smokers who smoke 1–15, 16–25, ≥26 cigarettes/day 
at recruitment, former smokers who quit <10, 10–19, ≥20 years ago, current 
occasional smoker of cigarettes or other types of tobacco, current/former smokers 
with unknown intensity or time since cessation and unknown smoking status and 
cigarette 
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smoking duration for current and former smokers (six categories: never, <10, 10–19, 
20–29, ≥30 years and unknown). The following variables that were tested in the 
model, BMI, education level, milk and animal protein intake, did not affect the model 
parameters and consequently were not included in the final models. All models met 
the proportional hazard assumption, tested using the Schoenfeld goodness-of-fit test. 
 
The rMED score was assessed as a continuous variable (per 4-unit) and as a 
categorical variable (low, medium and high). Additional models were created to 
assess the risk of UCC by tumor aggressiveness and age at diagnosis, using the 
Wald statistic to assess the homogeneity of risk between outcomes. Plausible effect 
modification was explored for sex, smoking status (never, former, current [all] and 
current heavy long-term smokers defined as smokers of ≥15 cigarettes/ day at 
baseline who have smoked for ≥15 years), BMI (<25 vs. ≥25 kg/m2) and European 
Region (Northern, Middle and Southern). Interaction terms were modeled between 
each of these separate variables and the categorical rMED score, and tested using 
the log-likelihood ratio test, while adjusting for energy intake and smoking status and 
duration. Sensitivity analyses included repeating the analysis (i) excluding the first 2 
years of follow-up to control for potential changes in diet due to early symptoms of 
bladder cancer, (ii) using an rMED score excluding alcohol, since alcohol is a 
recognized risk factor for many cancers6 and (iii) using an rMED score replacing 
olive oil intake with the commonly used lipid ratio (monounsaturated plus 
polyunsaturated fatty acids divided by saturated fatty acids). 
 
RESULTS 
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Participants (477,312) were followed-up for a mean of 11.0 years (>4.5 million 
person-years). During this period 1,575 first primary bladder cancer cases were 
diagnosed (Table 1), of which 1,425 (70.9% male) were UCC. In The Netherlands, 
the proportion of male cases was slightly lower, most likely due to fewer males 
overall. According to tumor stage and grade, 430 were aggressive and 413 were 
non-aggressive UCC tumors and for 582 subjects tumor aggressiveness was 
unknown (n=52) or not validated (n=530). The mean rMED score was 8.6 (SD 3.2), 
and was highest in Greece, Italy and Spain and lowest in Sweden and The 
Netherlands. Table 2 shows the baseline characteristics of the cohort according to 
level of adherence to the MD. In general, participants with a higher rMED score were 
more likely to be women, younger, never smokers and to have a higher education 
level, lower energy intake and to consume less milk and animal protein. The adjusted 
HRs for risk of UCC by categories of the rMED score are presented in Table 3. There 
was a negative but non-significant association between a high versus low rMED 
score and risk of UCC overall (HR: 0.84 [95% CI 0.69, 1.03]) and risk of aggressive 
(HR: 0.88 [95% CI 0.61, 1.28]) and risk of non-aggressive tumors (HR: 0.78 [95% CI 
0.54, 1.14]). When the rMED score was analyzed per 4-unit increase, the HR for risk 
of UCC was 0.95 (95% CI 0.87, 1.03) (data not shown). There was no evidence that 
the relation between the MD and UCC was modified by sex, age at diagnosis, BMI or 
European region (Table 3). However, when the association was assessed by 
smoking status, there was a significant inverse association between a high versus 
low score rMED score and UCC in current smokers (HR: 0.66 [95% CI 0.47, 0.93]), 
which was more pronounced in current heavy and long-term smokers (HR: 0.51 [95% 
CI 0.31, 0.86]) (data not shown). However, the interaction between smoking status 
(current, former, never) and the rMED score did not reach statistical significance. In 
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sensitivity analyses, the HR for a high versus low rMED score did not materially 
change after excluding the first 2 years of follow-up (HR: 0.89 [95% CI 0.72, 1.10]), 
when using a rMED excluding alcohol (HR 0.82 [95% CI 0.67, 1.02]) or when using 
an rMED including a fat ratio instead of olive oil (HR 0.88 [95% CI 0.73, 1.06]). 
 
DISCUSSION 
There is evidence that the Mediterranean dietary pattern has a protective role on risk 
of overall and specific types of cancer incidence and mortality (1–4). To our 
knowledge though, no epidemiological study to date has investigated the influence of 
the Mediterranean diet (MD) on bladder cancer. Bladder cancer is the eighth most 
common type of cancer in the world (5) and established risk factors include tobacco 
smoking, occupational exposure to aromatic amine carcinogens and Schistosoma 
haematobium infection (6,7). Indeed, previous studies in EPIC (19,20) and other 
cohorts (21,22) have found no overall effect of consumption of fruit and vegetables 
(19,21,22) as measured from dietary questionnaires, on bladder cancer risk. 
However, research in EPIC on dietary biomarkers has shown more promising results; 
higher plasma levels of carotenoids were associated with a decreased risk of UCC 
and there was a prominent protective effect of carotenoids and also vitamin C in 
current smokers.16 In line with this, we observed that a high rMED score was related 
to a significantly decreased risk of UCC in current smokers, especially among heavy 
long-term smokers. Although this finding should be interpreted with caution, since the 
interaction was not significant, it is biologically plausible that smokers may benefit 
more from following a MD, and this interaction is supported by previous 
epidemiological studies in other tumors (23). One theory is that the MD’s high 
antioxidant content (i.e., vitamin C, E, carotenoids, flavonoids and polyphenols) could 
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reduce or prevent the DNA damaging effect of free radicals and oxidants in cigarette 
smoke(23). The MD’s favorable fatty acid profile, with a high content of essential 
omega-3 fatty acids, could also be relevant for the inflammatory effects from tobacco 
smoke exposure(23). However, we cannot rule out that potential residual 
confounding by smoking could partly explain these results, since no association was 
observed in never smokers. The traditional MD also includes a relatively low 
consumption of red and processed meat and animal protein, which could also be 
beneficial for reducing risk of bladder cancer, as previous cohort studies have 
reported an increased risk of bladder cancer associated with dietary nitrites from 
processed meat24 and a high energy intake from animal protein(10). Therefore, 
certain dietary features of the MD and their potentially anti-carcinogenic mechanisms 
make an association plausible from a mechanistic point of view. Despite this, we 
found no evidence, at least not statistically significant, that the MD affected the 
overall risk of bladder cancer. However, the limitations of our study should be 
considered when interpreting the results, including potential measurement errors 
derived from dietary questionnaires, which could lead to systematic and random 
errors when estimating adherence to the MD. Although our adjustment for total 
energy intake would partly remove some of these errors(25) we cannot rule out that 
they have attenuated risk estimates and therefore could partly explain the lack of 
significant association we observed. In addition, we were unable to take into account 
any possible changes in dietary and lifestyle habits over time, although this would 
most likely have only attenuated the risk estimates as well. Finally, there were fewer 
female compared to male cases, which could have reduced the statistical power and 
accounted for the wider confidence intervals in female stratified analyses. The 
strengths of this study include its prospective design, long follow-up and multi-centric 
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European design covering a wide range of dietary intakes and lifestyle habits. In 
addition, we focused on UCC tumors only, to limit possible differential effects of the 
MD on other (rare) bladder cancer histologies. We also had sufficient information to 
be able to analyse UCC tumors according to risk of progression, which may influence 
its etiology, and evaluate whether certain cohort characteristics modified the 
relationship between the MD and bladder cancer. Since tobacco smoking is the most 
important bladder cancer risk factor we carefully adjusted for its potentially 
confounding effect by including smoking intensity, duration, time since quitting and 
exposure to second-hand smoke in all statistical models, and by presenting results 
stratified by smoking status. However, some residual confounding by tobacco 
smoking could still remain. The rMED score uses tertiles of intake as cut-offs instead 
of the frequently used medians, to give a better distribution of the subjects with 
different intakes. In summary, this is the first prospective study to examine the 
association between the MD and bladder cancer, and we found no conclusive 
evidence that this dietary pattern was related to bladder cancer risk. However, we 
cannot rule out that the MD may decrease the risk of UCC in current smokers, 
especially in heavy long-term smokers. Some studies have also observed only 
suggestive associations between the MD and overall cancer or certain cancers such 
as endometrial cancer.3 Nevertheless, in general the epidemiological evidence 
supports the protective role of the MD in overall cancer mortality and incidence, and 
in specific cancers of the stomach, colorectum and breast(3,4,17). Thus, the MD 
remains a good choice for cancer prevention in Europe. 
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Total             
(% male)
Urothelial cell 
carcinomans      
(% male)
Aggressive 
Urothelial cell 
carcinomas
1     
(% male)
Non-aggressive 
Urothelial cell 
carcinomas
1      
(% male)
France 67,385 (0) 699,360 31 (0) 24 (0) 13 (0.0) 6 (0) 9.8 (2.6)
Italy 44,541 (31.5) 500,407 183 (69.4) 143 (67.1) 45 (60.0) 42 (66.7) 11.0 (2.3)
Spain 40,002 (37.9) 482,582 146 (82.8) 138 (82.6) 24 (70.3) 61 (90.2) 11.2 (2.4)
UK 75,395 (30.3) 838,397 251 (69.7) 234 (72.7) 57 (66.7) 67 (73.1) 9.3 (2.7)
The Netherlands 36,505 (26.4) 431,252 104 (48.1) 101 (49.5) 30 (50.0) 29 (44.8) 6.3 (2.3)
Greece 26,032 (41.5) 247,711 45 (84.4) 25 (84.0) 5 (80.0) 6 (83.3) 12.8 (1.9)
Germany 48,583 (43.6) 480,614 199 (70.9) 171 (71.9) 46 (71.7) 40 (90) 7.3 (2.4)
Sweden 48,684 (43.6) 638,931 289 (74.7) 281 (74.7) 90 (72.2) 80 (78.8) 5.0 (2.3)
Denmark 55016 (47.8) 601,466 303 (79.2) 284 (79.6) 112 (74.1) 80 (90.0) 7.0 (2.7)
Norway 35,169 (0) 342,279 24 (0) 24 (0) 8 (0.0) 2 (0) 8.0 (2.2)
TOTAL 477,312 (29.8) 4563639 1,575 (70.4) 1,425 (70.9) 430 (65.6) 413 (77.7) 8.6 (3.2)
Country
Abbreviations: EPIC: European prospective investigation into cancer and nutrition. rMED: relative Mediterranean diet score. 
 1
Includes only cases 
diagnosed before 2007 with tumor aggressiveness validated by pathology reports (582 cases with unknown or not validated tumour aggressiveness). 
2
rMED score: ranges from 0 (lowest adherence) to 18 (highest adherence) and includes 9 components; vegetables, legumes, fruit and nuts, cereals, 
fresh fish and seafood, olive oil, alcohol, meat and dairy products. 
Table 1. Distribution of participants and bladder cancer cases and mean Mediterranean diet score across the 10 EPIC 
countries
Total Cohort 
(% male)
Person-
years
rMED,
2                        
mean (SD)
Bladder Cancer Cases
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Characteristics
Male, % 29.8 40.5 25.4 26.7
Age at enrolment, mean years 51.2 ± 9.9 51.8 ± 10.1 51.5 ± 9.5 50.4 ± 10.3
BMI, mean kg/m² 25.4 ± 4.3 25.6 ± 4.2 25.2 ± 1.2 25.7 ± 4.5
Height, mean cm 166.0 ± 8.9 168.9 ± 9.1 165.8 ±  8.6 163.5 ± 8.5
Weight, mean kg 70.2 ±  13.7 73.2 (14.2) 69.4 ±  13.4 68.6 ±  13.0
Energy intake, mean kcal/d 2,074.0  ± 619.2 2,124.3 ±  650.5 2,044.5 ± 606.2 2,070.3 ± 604.2
Smoking status, % 
Never
2
41.3 38.0 41.0 44.9
Never and no secondhand exposure
3
1.7 1.4 1.9 1.8
Current, 1-15 cigarettes/d 11.6 14.3 11.2 9.7
Current, 16-25 cigarettes/d 6.3 8.7 5.5 5.1
Current >26 cigarettes/d 1.8 2.0 1.4 2.3
Former smoker, quitting <10y ago 9.6 9.3 9.4 10.0
Former smoker, quitting 10-19y ago 8.2 7.8 8.5 8.1
Former smoker, quitting ≥20y ago 7.9 8.1 8.9 6.2
Current occasional cigarette smoker/ other 
types of tobacco 8.4 7 8.8 9.1
Current/Former, unknown intensity/ quitting 
time 1.6 2.1 1.8 1.0
 Unknown 1.7 1.3 1.8 1.9
Smoking duration, %
Never 43.0 39.4 42.9 46.7
<10 years 6.9 6.4 7.4 6.6
10-19 years 10.5 9.6 10.6 11.1
20-29 years 13.5 13.6 13.4 13.4
≥30 years 16.0 23.2 14.7 11.2
Missing 10.2 7.9 11.0 11.1
Educational level, %
No formal education 4.4 0.6 3.0 10.1
Primary school 25.6 30.2 22.4 26.0
Secondary school 20.4 17.8 21.5 21.4
Technical or Professional training 22.3 30.2 23,4 13.1
University degree 23.8 19.0 25.4 25.9
Not specified 3.6 2.2 4.4 3.5
Milk intake, mean g/d 199.0±211.9 286.6±259.5 190.2±195.8 129.6±145.9
Animal protein intake, mean g/1000kcal/d 25.3±8.8 26.5±8.1 25.9±8.9 23.3±8.9
All comparison between groups and tests for trend statistically significant at p<0.001. EPIC: European prospective 
investigation into cancer and nutrition. ¹rMED: relative Mediterranean Diet Score includes 9 components: vegetables, 
legumes, fruit, cereals, fresh fish, olive oil, alcohol, meat and dairy products from EPIC dietary questionnaire data (Low 
Score: 0 to 6, Medium Score: 7 to 10, High Score: 11 to 18). 
2
Never smokers (of cigarettes or other types of tabacco) but 
exposed to second-hand smoke (at home or work) or not known if exposed to second-hand smoke. 
3
Never smokers 
(cigarettes nor other types of tabacco) and never exposed to second-hand smoke (at home or work).
Table 2. Baseline characteristics of the 477,312 participants in the EPIC cohort according to level of adherence 
to the Mediterranean diet score 
Whole cohort    
(n=477,312)
rMED score
1
Low         
(131,522)
Medium   
(206,353)
High       
(139,437)
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Low                    Medium               High              
HR (95% CI)
1
HR (95% CI)
2
HR (95% CI)
2
Overall
No. cases/ population 1,425/477,312 588/ 131,522 565/ 206,353 272/ 139,437
Total Cohort 1,425/477,312 1 [Referent] 0.94 (0.83, 1.07) 0.84 (0.69, 1.03) 0.107 N/A
Tumour Aggressiveness
  Non-aggressive 413/ 477,312 1 [Referent] 0.87 (0.69, 1.90) 0.78 (0.54, 1.14) 0.147
  Aggressive 430/ 477,312 1 [Referent] 0.89 (0.69, 1.13) 0.88 (0.61, 1.28) 0.405 0.657
4
Age at diagnosis
  <65 years 656/ 477,312 1 [Referent] 0.84 (0.69, 1.02) 0.81 (0.61, 1.07) 0.102
  ≥65 years 769/ 477,312 1 [Referent] 1.02 (0.86, 1.21) 0.86 (0.64, 1.14) 0.504 0.756
4
Sex
  Men 1010/ 141,240 1 [Referent] 0.95 (0.81, 1.01) 0.79 (0.62, 1.01) 0.094
  Women 415/ 335,062 1 [Referent] 0.92 (0.73, 1.18) 0.95 (0.68, 1.33) 0.692 0.709
5
Smoking Status
2
  Current smokers (all) 586/107,089 1 [Referent] 0.92 (0.76, 1.14) 0.66 (0.47, 0.93) 0.043
  Current heavy smokers
3
291/45760 1 [Referent] 0.77 (0.57, 1.05) 0.51 (0.31, 0.86) 0.011
  Former Smokers 518/ 127,148 1 [Referent] 0.85 (0.69, 1.05) 0.97 (0.71, 1.33) 0.529
  Never Smokers 309/ 233,342 1 [Referent] 1.15 (0.86, 1.55) 1.08 (0.71, 1.64) 0.617 0.581
5
BMI
 <25kg/m
2
507/ 246,837 1 [Referent] 0.98 (0.79, 1.21) 0.92 (0.66, 1.28) 0.637
 ≥25kg/m
2
918/ 230,475 1 [Referent] 0.93 (0.79, 1.10) 0.82 (0.64, 1.06) 0.138 0.321
5
European Region
  Northern 589/ 138,869 1 [Referent] 0.94 (0.79, 1.14) 0.93 (0.60, 1.44) 0.535
  Middle 523/ 199,849 1 [Referent] 0.93 (0.76, 1.12) 0.85 (0.62, 1.17) 0.288
  Southern 313/ 138,594 1 [Referent] 0.89 (0.45, 1.76) 0.78 (0.39, 1.54) 0.237 0.832
5
 
2
Smoking status strata exclude 9,733 individuals (12 cases) with missing information on smoking status
3
Current heavy smokers includes current smokers of ≥15 cigarettes/day and for ≥15years duration
4
Wald test for homogeneity
c
Log likelyhood ratio test.
P-heter-
ogeneity
Abbreviations: UCC; Urothelial cell carcinoma, EPIC; European Prospective Investigation into Cancer and Nutrition. 
rMED: relative Mediterranean diet score.
1
Cox models stratified by sex, age at diagnosis and center and adjusted for energy intake, smoking status (including 
exposure to secondhand smoke in never smokers), smoking intensity, duration and time since quitting (where 
Table 3. Association between adherence to the Mediterranean diet and UCC bladder cancer in EPIC, by 
participants characteristics  
Stratified by
1 No. cases/  
population
rMED score - categorical
P-trend
 
